From: Positive side effects of Ca antagonists for osteoarthritic joints—results of an in vivo pilot study
Drugs | Treated patients (mean score) | Number of patients | SD | p value |
---|---|---|---|---|
Adalat® (Nifedipine) | 4.0 | 5 | 3 | 0 |
Amlodipine® (Amlodipine) | 3.5 | 22 | 2.97 | 0 |
Azupamil® (Verapamil) | 6 | 8 | 3.59 | 0 |
Carmen® (Lercanidipine) | 3 | 21 | 2.91 | 0 |
Escor® (Nilvadipine) | 6 | 5 | 4.72 | 0 |
Felodipine® (Felodipine) | 5 | 7 | 4.1 | 0 |
Nifedipine® (Nifedipine) | 6.2 | 15 | 5.21 | 0 |
Nitrendipine® (Nitrendipin) | 2.1 | 8 | 2.8 | 0 |
Norvasc® (Amlodipine) | 4.8 | 48 | 5 | 0 |
Verapamil® (Verapamil) | 6.9 | 49 | 5 | 0 |
Control group | 6.2 | 212 | 4.85 | 0 |